1. Home
  2. PHAR vs VREX Comparison

PHAR vs VREX Comparison

Compare PHAR & VREX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PHAR
  • VREX
  • Stock Information
  • Founded
  • PHAR 1988
  • VREX 2016
  • Country
  • PHAR Netherlands
  • VREX United States
  • Employees
  • PHAR N/A
  • VREX 2300
  • Industry
  • PHAR Biotechnology: Pharmaceutical Preparations
  • VREX Industrial Machinery/Components
  • Sector
  • PHAR Health Care
  • VREX Technology
  • Exchange
  • PHAR Nasdaq
  • VREX Nasdaq
  • Market Cap
  • PHAR 618.3M
  • VREX 576.8M
  • IPO Year
  • PHAR N/A
  • VREX N/A
  • Fundamental
  • Price
  • PHAR $8.42
  • VREX $14.38
  • Analyst Decision
  • PHAR Strong Buy
  • VREX Strong Buy
  • Analyst Count
  • PHAR 3
  • VREX 1
  • Target Price
  • PHAR $27.00
  • VREX $21.00
  • AVG Volume (30 Days)
  • PHAR 5.6K
  • VREX 377.8K
  • Earning Date
  • PHAR 03-13-2025
  • VREX 02-06-2025
  • Dividend Yield
  • PHAR N/A
  • VREX N/A
  • EPS Growth
  • PHAR N/A
  • VREX N/A
  • EPS
  • PHAR N/A
  • VREX N/A
  • Revenue
  • PHAR $285,745,000.00
  • VREX $811,000,000.00
  • Revenue This Year
  • PHAR $20.08
  • VREX $3.50
  • Revenue Next Year
  • PHAR $9.22
  • VREX $3.37
  • P/E Ratio
  • PHAR N/A
  • VREX N/A
  • Revenue Growth
  • PHAR 30.64
  • VREX N/A
  • 52 Week Low
  • PHAR $6.65
  • VREX $10.19
  • 52 Week High
  • PHAR $13.20
  • VREX $19.91
  • Technical
  • Relative Strength Index (RSI)
  • PHAR 40.05
  • VREX 55.87
  • Support Level
  • PHAR $7.95
  • VREX $13.35
  • Resistance Level
  • PHAR $9.35
  • VREX $14.08
  • Average True Range (ATR)
  • PHAR 0.52
  • VREX 0.45
  • MACD
  • PHAR -0.16
  • VREX 0.11
  • Stochastic Oscillator
  • PHAR 22.76
  • VREX 95.73

About PHAR Pharming Group N.V.

Pharming Group is a global biopharmaceutical company dedicated to transforming the lives of patients with rare, debilitating, and life-threatening diseases. It is commercializing and developing an innovative portfolio of protein replacement therapies and precision medicines to serve the unserved rare disease patients. Its product includes Ruconest. The revenue is generated from the United States.

About VREX Varex Imaging Corporation

Varex Imaging Corp designs and manufactures X-ray imaging components. It operates in two segments Medical and Industrial. The Medical segment, which is the key revenue driver, designs, manufactures, sells, and services X-ray imaging components, including X-ray tubes, digital detectors and accessories, generators, and heat exchangers among other products. The Industrial segment designs, manufactures, sells, and services Linatron X-ray accelerators, X-ray tubes, digital flat panel detectors, high-voltage connectors, and coolers. Geographically, the company generates maximum revenue from Europe, Middle East, and Africa (EMEA) and the rest from the Americas and Asia Pacific region.

Share on Social Networks: